Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Thumbay Media becomes the first and biggest publisher in the Northern Emirates, with a five-magazine portfolio; Living Gulf strengthens its regional media presence

    June 18, 2026

    DIFC Future of Finance Report: Digital native, AI driven challenger banks redefining banking models, signalling industry’s biggest shift since 2008

    June 18, 2026

    MOZN Becomes Only Middle-Eastern Company Named a Global Leader by Chartis for Enterprise Fraud

    June 18, 2026
    Middle East NewsreportMiddle East Newsreport
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Middle East NewsreportMiddle East Newsreport
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Related Posts

    U.S. Air Force Awards GA-ASI Production Contract for FQ-42A CCA

    June 18, 2026

    U.S. Polo Assn. Returns to Downtown London as Official Apparel and Jersey Partner of Chestertons Polo in the Park

    June 9, 2026

    GA-ASI Announces Investments in Six Dutch Companies

    June 9, 2026

    Graid Technology Launches VROC(TM) by Graid Technology with 24-Month Roadmap and Tier 1 OEM Support

    June 2, 2026

    Resin Solutions LLC Introduces “Stratix(TM)” Brand Architecture for Products Serving the Aerospace and Defense Applications

    June 1, 2026

    OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value

    May 27, 2026
    Last News

    Portugal attack stalls in DR Congo World Cup draw

    June 18, 2026

    HOUSTON, TEXAS / MENA Newswire / – Portugal opened its FIFA World Cup Group K…

    France opens World Cup with 3-1 win over Senegal

    June 17, 2026

    EAST RUTHERFORD, NEW JERSEY / MENA Newswire / – France opened their FIFA World Cup…

    China raises emergency response after Qinghai earthquake

    June 17, 2026

    QINGHAI, CHINA / MENA Newswire / – China activated a Level-IV national earthquake disaster emergency…

    UAE President and Sisi discuss ties and region in Cairo

    June 16, 2026

    CAIRO / MENA Newswire / – UAE President Sheikh Mohamed bin Zayed Al Nahyan met…

    © 2026 Middle East Newsreport | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.